Do you want to read an article? Please log in or register.
Global temporal trends of DR-related blindness and vision loss from 1990 to 2021: an age-period-cohort analysis of the contributions of type 1 and type 2 diabetes
Retinal Diseases
Related content
Blindness and Vision Impairment
The Right to Women's Sight: Global, Regional, and National Burden of Blindness and Vision Loss in Women, 1990-2021
Am J Ophthalmol
Xia L, Weng W, Wang J, Dai L, Guo S, Pu Y, Cai T, Yang P
doi: 10.1016/j.ajo.2025.12.005
Retinal Diseases
Glucagon-like peptide-1 receptor agonists and risk of diabetic retinopathy in type 2 diabetes: A systematic review and network meta-analysis of randomized clinical trials
Surv Ophthalmol
Ortiz-Seller A, Real JT, Morcillo E, Ortiz JL
doi: 10.1016/j.survophthal.2026.08.007
Macular Diseases
Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study
Ophthalmology
Cai CX, Toy B, Martin B, Fan R, Westlund E, Tran D, Nishimura A, Lee H, Leng T, Nagy P, Mathioudakis N, Zhang L, Hribar M, Chen A, Armbrust K, Goetz K, Baxter S, Boland MV, Brown EN, Tsui E, Barkmeier AJ, Wang S, Mehta N, Stocking JC, O'Keefe G, Lee CS, Payne PRO, O'Brien WJ, DuVall S, Alshammari T, Falconer T, Dorr DA, Humes I, McCoy D, Adibuzzaman M, Mahmood R, Morgan-Cooper H, Desai P, Kothari SY, Sena A, Blacketer C, Ostropolets A, Shoaibi A, Rao G, Hripcsak G, Ryan P, Suchard MA
doi: 10.1016/j.ophtha.2026.05.034
RECOMMENDED
Retinal Diseases
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Systemic and Ocular Vascular Complications in Patients with Type 2 Diabetes and Diabetic Retinopathy
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Am J Ophthalmol
Shah J, Makwana B, Panchal K, Patel V, Patel T, Khadke S, Verma A, Vivekanandan S, Kong Y, Upadhyay J, Dani SS, Ramsey KM, Ganatra S, Ramsey DJ
doi: 10.1016/j.ajo.2026.04.021
Retinal Diseases
30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes
Diabetes Care
Calligaro LI, Liew G, Cho YH, Allen DW, Pryke A, Cusumano J, Chan A, Craig ME, Donaghue KC
doi: 10.2337/dc26-0388
Macular DiseasesRetinal Diseases
Trends in Prevalence and Incidence of Diabetic Retinal Disease Across Age Cohorts
Ophthalmol Retina
Chang AY, Yu Y, Cardillo S, Hubbard RA, VanderBeek BL
doi: 10.1016/j.oret.2026.03.007
Retinal Diseases
Effect of a Multifactorial Intervention on Retinopathy in People With Type 2 Diabetes: A Secondary Analysis of the J-DOIT3 Randomized Clinical Trial
JAMA Ophthalmol
Sasako T, Ueki K, Miyoshi K, Miyake K, Aoyama T, Okazaki Y, Ishizuka N, Yamauchi T, Noda M, Kadowaki T, J-DOIT3 Study Group
doi: 10.1001/jamaophthalmol.2025.3819
COMMENTED
Retinal Diseases
Ocular Outcomes with Tirzepatide Versus Glucagon-like Peptide-1 Receptor Agonists in Type 2 Diabetes
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
Ophthalmol Retina
Hong AT, Lin F, Keenan JD, Stewart JM
doi: 10.1016/j.oret.2026.02.002
Macular Diseases
Association of Mesopic and Dark-Adapted Retinal Sensitivity With Type 1 Macular Neovascularization in Age-Related Macular Degeneration
Invest Ophthalmol Vis Sci
Karaca I, Wei Y, Nelson R, Sassen SH, Daynes K, Clark F, Brown T, Messina A, Pfau M, Zhang Y, Schmitz-Valckenberg S, Fleckenstein M
doi: 10.1167/iovs.66.15.45